Good read on Ron Walker's war on cancer.
Mr Walkers treatment with Merck's drug Keytruda cost$350,ooo
Edison the analysts have projected cavatek's average price will be $75,000 in the US and $45,000
in other markets.
If the combination studies show the two drugs work best together that is an expensive drug cocktail
and will it be put on the Pharmaceutical Benefits Scheme for everybody to have access if need be?
- Forums
- ASX - By Stock
- VLA
- Top Stock Pick for 2015
Top Stock Pick for 2015, page-57
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)